Onxeo is a France-based biotechnology company that develops and commercializes oncology drugs for the treatment of cancer.
Business Model:
Revenue: $11M
Employees: 11-50
Address: 49 Boulevard du General Martial Valin
City: Paris
State: île-de-france
Zip: 75015
Country: FR
Onxeo is a France-based biotechnology company that develops and commercializes oncology drugs for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
Other
IPO Date:
12/16/2005
Ticker Symbol:
ALONX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2017 | Private Placement | $16.8M | 9/2016 | Unattributed | $12.5M | 9/2016 | Equity | $14M | 4/2022 | Post-IPO Equity | 2 | $8.7M |
Financière de la Montagne Invus Financière de la Montagne Invus |
10/2019 | Grant | $368.6k | 4/2022 | Post-IPO Debt | $4.4M | 10/2019 | Post-IPO Debt | $184.3k | 6/2017 | Post-IPO Equity | $16.7M | 3/2009 | Grant | 1 | $8.3M |
Oséo Oséo Oséo Oséo |
4/2021 | Post-IPO Equity | $11.6M | 9/2016 | Post-IPO Equity | $14.1M | 7/2013 | Post-IPO Equity | 1 | $5.6M |
Bpifrance Bpifrance Bpifrance Bpifrance |
6/2018 | Post-IPO Equity | 1 | $6.3M |
Nice &a; Green SA Nice &a; Green SA Nice &a; Green SA Nice &a; Green SA |
---|
Announced Date | Name | Price |
---|---|---|
2/2016 | DNA Therapeutics | |
6/2007 | TopoTarget Switzerland | |
6/2002 | TopoTarget UK Limited |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|